Eiger BioPharmaceuticals Competitors and Similar CompaniesClear all

Eiger BioPharmaceuticals's competitors and similar companies include Cipla, Cadila Pharmaceuticals and CSL Behring.

	Eiger BioPharmaceuticals Eiger is a biopharmaceutical company developing new antiviral agents against novel targets in the treatment of hepatitis.	Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.	Cadila Pharmaceuticals Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients.	CSL Behring CSL Behring is a provider of life-saving medicines.
Founding Date	Founding Date 2008	Founding Date 1935	Founding Date 1951	Founding Date 1904
Type	Type Public	Type Public	Type Private	Type Subsidiary
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Palo Alto, US HQ	Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more	Locations Bavla, IN HQ Akaki, ET Dholka, IN Chiyoda City, JP Nairobi, KE Moskva, RU Ascot, GB see more	Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more
Employees	Employees 2433% increase	Employees 27,764	Employees 8,5201% increase	Employees 7,5692% decrease
Financial
Revenue (est.)	Revenue (est.) $15.8m (FY, 2023)	Revenue (est.) ₹277.1b (FY, 2026)	Revenue (est.) N/A	Revenue (est.) $7.9b (FY, 2020)
Cost of goods	Cost of goods $24k (FY, 2023)	Cost of goods ₹97.2b (FY, 2026)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit ₹184.4b (FY, 2026)	Gross profit N/A	Gross profit $4.5b (FY, 2020)
Net income	Net income ($75m) (FY, 2023)	Net income ₹38.7b (FY, 2026)	Net income N/A	Net income N/A